Sirt1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
**Gene:** SIRT1
**UniProt ID:** Q96EB6
**PDB ID:** 4IG0, 1ZC4, 5B2R
**Molecular Weight:** 81 kDa
**Subcellular Localization:** Nucleus, Cytoplasm
**Protein Family:** Sirtuin family (Class III HDAC)
SIRT1 (Sirtuin 1) is an 81 kDa NAD+-dependent class III histone deacetylase that removes acetyl groups from lysine residues on histones and various regulatory proteins. As a master regulator of cellular stress responses, metabolism, and aging, SIRT1 has emerged as a critical protective factor in neurodegenerative diseases. SIRT1 belongs to the sirtuin family of proteins conserved from yeast to humans.
SIRT1 has a modular organization:
- N-terminal region: Contains nuclear localization signals and regulatory domains
- Catalytic core: The conserved sirtuin domain (~275 aa) contains the NAD+-binding Rossmann fold and the small Rossmann fold
- C-terminal region: Regulatory element that auto-inhibits activity
The active site contains a conserved catalytic triad: His-363, Asn-395, and His-402 (in human SIRT1). The enzyme requires NAD+ as a cofactor, linking its activity to cellular energy status.
SIRT1 functions in the nervous system:
- Epigenetic Regulation: Deacetylates H3K9, H3K14, H4K16 to modulate chromatin
- Metabolic Control: Activates PGC-1α for mitochondrial biogenesis
- Stress Response: Deacetylates FOXO factors for antioxidant gene expression
- Inflammation: Inhibits NF-κB signaling through p65 deacetylation
- Autophagy: Promotes autophagy through deacetylation of autophagy proteins
- Synaptic Plasticity: Regulates synaptic protein function and memory formation
SIRT1 is protective through multiple mechanisms:
- Deacetylates tau to reduce aggregation
- Activates ADAM10 for non-amyloidogenic APP processing
- Reduces Aβ-induced neurotoxicity
- Anti-inflammatory effects via NF-κB inhibition
- Promotes mitochondrial function
- Protects dopaminergic neurons
- Activates PGC-1α for mitochondrial biogenesis
- Reduces α-synuclein aggregation
- Enhances autophagy
- Anti-apoptotic through FOXO activation
- Mutant huntingtin disrupts SIRT1 function
- SIRT1 activation reduces mHTT toxicity
- PGC-1α activation compensates for mitochondrial dysfunction
- Promotes clearance of mutant protein
| Agent |
Mechanism |
Status |
Notes |
| Resveratrol |
SIRT1 activator |
Phase II/III |
Natural compound, limited bioavailability |
| SRT1720 |
SIRT1 activator |
Preclinical |
1000x more potent than resveratrol |
| SRT2104 |
SIRT1 activator |
Phase I |
Good brain penetration |
| NAD+ precursors |
SIRT1 substrate |
Phase II |
NMN, NR increase SIRT1 activity |
| EX-527 |
SIRT1 inhibitor |
Research |
Used to study SIRT1 biology |
- "SIRT1 protects against neurodegeneration" - Nature (2009) PMID:19371342
- "SIRT1 and Alzheimer's disease" - JAD (2020) PMID:32804117
- "NAD+ metabolism in brain aging" - Cell Metab (2021) PMID:34270924
The study of Sirt1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Haigis MC et al. Cell. 2006 PMID:16611638
- Qin W et al. J Biol Chem. 2006 PMID:16617171
- Kim D et al. Nat Rev Neurosci. 2007 PMID:17982452
- Albani D et al. J Alzheimer Dis. 2014 PMID:24625797
- Bonkowski MS et al. Nature. 2014 PMID:24676469